Genetically informed healthcare

Genetically informed healthcare

Cell & Gene Therapy

Information

Seques is the first global healthcare communications agency to specialize in the field of genomics. Advances in the understanding of the genetic basis of disease are leading to major developments in the diagnosis and treatment of a wide range of both common and rare disorders. Seques combines expertise in genomics with a global agency platform and extensive experience in healthcare communications. We partner with leading global pharmaceutical, biotech and diagnostic companies to create scientifically accurate and impactful programmes designed to inform healthcare professionals, patients and other stakeholder groups. The Seques brand name and microarray-inspired symbol reinforce our focus on genomic medicine for the management of both common and rare diseases. Seques is an AMICULUM® agency. AMICULUM is an independent global healthcare communications and consulting business with offices in New Zealand, China, Singapore, the UAE, Switzerland, the UK and the USA (www.amiculum.biz).
Service or Product Link
https://www.seques.biz/
ComradisComradis is a full-service healthcare communications agency working exclusively on projects related to rare diseases and uncommon cancers. With capacity to support clients at every stage of treatment development, Comradis has specialist experience in a broad range of communication, commercialization and community-focused activities. Our goal is to ensure that novel therapies reach those that need them as quickly and cost-efficiently as possible.   We work with pharmaceutical companies, rare disease specialists and patient advocacy organizations from our offices in New Zealand, China, Singapore, UAE, Switzerland, the UK and USA.    Comradis is part of AMICULUM, an independent global healthcare communications and learning business established in 2001.

Log in